A. PREVENTING TRANSMISSION
o Continued screening of blood donors for the presence of hepatitis B
antigens
o The use of disposable syringes, needles, and lancets and the introduction
of needleless IV
o Good personal hygiene is fundamental to infection control. In the
clinical laboratory, work areas should be disinfected daily. Gloves are
worn when handling all blood and body fluids as well as HBAg positive
specimens.
o Eating and smoking are prohibited in the laboratory and in other areas
exposed to secretions, blood products.
B. Active Immunization: Hepatitis B Vaccine
o Active immunization is recommended for individuals at high risk for
hepatitis B (eg, health care personnel and hemodialysis patients). In
addition, individuals with hepatitis C and other chronic liver diseases
should receive the vaccine.
o Administered IM (in the deltoid muscle in adults) in three doses, the
second and third doses 1 & 6 months after the first dose. The third dose
is very important in producing prolonged immunity.
o Antibody response may be measured by anti-HBs levels 1 to 3 months
after completing the basic course of vaccine
o Universal vaccination of all infants.
C. PASSIVE IMMUNITY: HEPATITIS B IMMUNE GLOBULIN
o Hepatitis B immune globulin (HBIG) provides passive immunity to
hepatitis B and is indicated for people exposed to HBV who have never
had hepatitis B and have never received hepatitis B vaccine. Specific
indications for postexposure vaccine with HBIG include :
) 1 (inadvertent exposure to HBAg-positive blood through percutaneous
(needlestick) or transmucosal (splashes in contact with mucous
membrane) routes ,
) 2 ( sexual contact with people positive for HBAg, and
) 3 ( perinatal exposure (babies born to HBV-infected mothers should
receive HBIG within 12 hours of delivery .)